medical device guru

Imaging Visualization & Navigation

Nanox Signs Agreement With The Gateway Group for the Deployment of 1,000 Nanox.ARC Units Across Australia, New Zealand, and Norway 

NANO-X IMAGING LTD (www.nanox.vision) (“Nanox” or the “Company”), an innovative medical imaging technology company, announces it has secured an exclusive distribution deal with The Gateway Group (“Gateway”), one of Australia’s largest independent product distributors including health, wellness, medical supplies and devices. The agreement...

March 2, 2020

Surgery and Surgical Robotics

Baxter Launches Peri-Strips Dry With Secure Grip Technology for Reliable Staple Line Reinforcement in Surgical Procedures 

Baxter International Inc., a global leader in advancing surgical innovation, announced 510(k) clearance from the U.S. Food and Drug Administration for a new generation of its Peri-Strips Dry with Veritas Collagen Matrix (PSDV) product, known as PSDV with Secure Grip. Now available with...

March 2, 2020

Diagnostics & Healthcare News

U.S. FDA Grants PAVmed Subsidiary, Lucid Diagnostics, Breakthrough Device Designation for its EsoGuard Esophageal DNA Test 

PAVmed Inc., a highly differentiated, multiproduct medical device company, today announced that the Company’s majority owned subsidiary, Lucid Diagnostics Inc. (“Lucid”), has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its EsoGuard™ Esophageal DNA Test...

February 27, 2020

Imaging Visualization & Navigation

Arizona Startup Emagine Solutions Technology Receives FDA 510(k) Clearance of its VistaScan Mobile Ultrasound

Emagine Solutions Technology, an award-winning medical software device company located in Tucson, announced that it has received clearance from the U.S. Food & Drug Administration (“FDA”) to market its VistaScan mobile ultrasound platform. The VistaScan platform transforms a clinician’s cell phone...

February 27, 2020

Cardiovascular / Cardiology

Endotronix Announces Enrollment of the First Patients in the PROACTIVE-HF Pivotal Trial 

Endotronix, a digital health and medical technology company dedicated to advancing the treatment of chronic heart failure (HF), today announced the enrollment of the first two patients in the PROACTIVE-HF pivotal trial. The trial is a pre-market investigational device exempt...

February 26, 2020

Imaging Visualization & Navigation

WaveGuide Launches World’s First Portable NMR Device: the WaveGuide Formµla 

WaveGuide Corporation, an innovator of portable micro NMR (Nuclear Magnetic Resonance) instruments, today launched its new WaveGuide Formµla™, the world’s only battery-powered, compact scientific instrument that performs rapid screening and diagnostics of solid and liquid substances spanning an array of...

February 26, 2020

Biologics, Wound Care, Infection Prevention

Cynosure Launches Potenza Radiofrequency Microneedling Device Expanding Company’s Growing Skin Revitalization Portfolio

Cynosure, the global leader in medical aesthetics, announced today the U.S. Food and Drug Administration (FDA) clearance of the Potenza™ radiofrequency (RF) microneedling device, the first and only FDA-cleared four-mode RF microneedling device offering clinicians unrivaled versatility and personalized treatments...

February 25, 2020

Diagnostics & Healthcare News

ReadCoor, Inc. Unveils True Spatial Sequencing Platform to Drive Groundbreaking Insights into Immuno-oncology, Neuroscience, and Infectious Disease 

ReadCoor, Inc., a company leading true multi-omic spatial sequencing, today unveils its first product line, including multi-omic spatial sequencing assays and the RC2 instrument. The platform is powered by ReadCoor’s proprietary FISSEQ (Fluorescent in situ Sequencing) technology, which combines the massive multiplexity of next-generation sequencing (NGS)...

February 24, 2020

Diagnostics & Healthcare News

ImmunoPrecise Launches Coronavirus Vaccine and Therapeutic Antibody Program

ImmunoPrecise Antibodies Ltd (the “Company”), a provider of best-in-class therapeutic antibody discovery capabilities for the global industry, announces its commitment to the development of innovative vaccines against the new coronavirus originating in Wuhan, China (SARS-CoV-2) as well as coronavirus-neutralizing antibodies, addressing both prophylactic...

February 20, 2020